The most recent scientific evidence shows that imbalances in the gut microbiome are associated with a wide range of disorders, both intestinal and extra-intestinal. The gut microbiome is therefore becoming increasingly central in clinical practice, finding applications in diagnostic support, prognosis, and risk assessment for numerous conditions. For this reason, in 2024 an international consensus was established, defining a standardized framework for microbiome-based diagnostics and providing best practices for the analysis of the human microbiome. Microbiome Analytics fully complies with these guidelines, making them a foundational principle of quality and reliability.
Specifically:
Recognized methodologies: our reports rely exclusively on internationally validated techniques for microbiome analysis, such as DNA amplicon sequencing and metagenomic sequencing;
Quality controls: each sequencing analysis is accompanied by negative and positive controls, ensuring the robustness and reliability of the results;
Validated protocols: our procedures for sample collection, DNA extraction, sequencing library preparation, as well as the bioinformatic pipelines and reference databases, are supported by extensive scientific literature and can be consulted at the following link;
Complete, transparent, informative, and robust reports: each report provides a clear and understandable description of:
- diversity, composition, and structure of the microbiota;
- abundance of health-promoting bacteria;
- deviations from the reference microbiota of a healthy population.
Scientific rigor: in line with international guidelines, Microbiome Analytics does not perform any type of inference on metabolic potential based solely on taxonomic data, ensuring the highest interpretative accuracy of the results.